| [1] |
Mistry S, Harrison JR, Smith DJ, et al. The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: a systema-tic review[J]. J Affect Disord, 2018, 234:148-155.
doi: 10.1016/j.jad.2018.02.005
URL
|
| [2] |
Mega JL, Stitziel NO, Smith JG, et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials[J]. Lancet, 2015, 385(9984):2264-2271.
doi: 10.1016/S0140-6736(14)61730-X
pmid: 25748612
|
| [3] |
Tada H, Melander O, Louie JZ, et al. Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history[J]. Eur Heart J, 2016, 37(6):561-567.
doi: 10.1093/eurheartj/ehv462
URL
|
| [4] |
Natarajan P, Young R, Stitziel NO, et al. Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting[J]. Circulation, 2017, 135(22):2091-2101.
doi: 10.1161/CIRCULATIONAHA.116.024436
pmid: 28223407
|
| [5] |
Khera AV, Emdin CA, Drake I, et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease[J]. N Engl J Med, 2016, 375(24):2349-2358.
doi: 10.1056/NEJMoa1605086
URL
|
| [6] |
Xu Z, Liu H, Sun C, et al. Association between a genetic risk score based on single nucleotide polymorphisms of coronary artery disease-related genes and left main coronary artery disease[J]. Biomed Res Int, 2018, 2018:8610368.
|
| [7] |
Khera AV, Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations[J]. Nat Genet, 2018, 50(9):1219-1224.
doi: 10.1038/s41588-018-0183-z
pmid: 30104762
|
| [8] |
韩俊庆. 临床肿瘤学指南[M]. 山东科学技术出版社, 2016.
|
| [9] |
Markham MJ, Wachter K, Agarwal N, et al. Clinical Cancer Advances 2020: annual report on progress against cancer from the American Society of Clinical Oncology[J]. J Clin Oncol, 2020, 38(10):1081.
|
| [10] |
Dai J, Lv J, Zhu M, et al. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations[J]. Lancet Respir Med, 2019, 7(10):881-891.
doi: 10.1016/S2213-2600(19)30144-4
URL
|
| [11] |
van Veen EM, Brentnall AR, Byers H, et al. Use of single-nucleotide polymorphisms and mammographic density plus classic risk factors for breast cancer risk prediction[J]. JAMA Oncol, 2018, 4(4):476-482.
doi: 10.1001/jamaoncol.2017.4881
URL
|
| [12] |
Läll K, Lepamets M, Palover M, et al. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification[J]. BMC Cancer, 2019, 19(1):557.
doi: 10.1186/s12885-019-5783-1
URL
|
| [13] |
Palmer JR. Polygenic risk scores for breast cancer risk prediction: lessons learned and future opportunities[J]. J Natl Cancer Inst, 2020, 112(6):555-556.
doi: 10.1093/jnci/djz176
pmid: 31553456
|
| [14] |
Wen W, Shu XO, Guo X, et al. Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry[J]. Breast Cancer Res, 2016, 18(1):124.
doi: 10.1186/s13058-016-0786-1
URL
|
| [15] |
Wang Z, Liu Q, Wilson CL, et al. Polygenic determinants for subsequent breast cancer risk in survivors of childhood cancer: the St Jude Lifetime Cohort Study (SJLIFE)[J]. Clin Cancer Res, 2018, 24(24):6230-6235.
doi: 10.1158/1078-0432.CCR-18-1775
URL
|
| [16] |
Lencz T, Knowles E, Davies G, et al. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium(COGENT)[J]. Mol Psychiatry, 2014, 19(2):168-174.
doi: 10.1038/mp.2013.166
URL
|
| [17] |
Hubbard L, Tansey KE, Rai D, et al. Evidence of common genetic overlap between schizophrenia and cognition[J]. Schizophr Bull, 2016, 42(3):832-842.
doi: 10.1093/schbul/sbv168
pmid: 26678674
|
| [18] |
Córdova-Palomera A, Kaufmann T, Bettella F, et al. Effects of autozygosity and schizophrenia polygenic risk on cognitive and brain developmental trajectories[J]. Eur J Hum Genet, 2018, 26(7):1049-1059.
doi: 10.1038/s41431-018-0134-2
pmid: 29700391
|
| [19] |
Mallet J, Le Strat Y, Dubertret C, et al. Polygenic risk scores shed light on the relationship between schizophrenia and cognitive functioning: review and meta-analysis[J]. J Clin Med, 2020, 9(2):341.
doi: 10.3390/jcm9020341
URL
|
| [20] |
Hettige NC, Cole CB, Khalid S, et al. Polygenic risk score prediction of antipsychotic dosage in schizophrenia[J]. Schizophr Res, 2016, 170(2-3):265-270.
doi: 10.1016/j.schres.2015.12.015
pmid: 26778674
|
| [21] |
Jones HJ, Hubbard L, Mitchell RE, et al. Association of genetic risk for rheumatoid arthritis with cognitive and psychiatric phenotypes across childhood and adolescence[J]. JAMA Netw Open, 2019, 2(6):e196118.
|
| [22] |
Ge T, Chen CY, Ni Y, et al. Polygenic prediction via Bayesian regression and continuous shrinkage priors[J]. Nat Commun, 2019, 10(1):1776.
doi: 10.1038/s41467-019-09718-5
URL
|
| [23] |
Khan MAB, Hashim MJ, King JK, et al. Epidemiology of type 2 diabetes-global burden of disease and forecasted trends[J]. J Epidemiol Glob Health, 2020, 10(1):107-111.
doi: 10.2991/jegh.k.191028.001
URL
|
| [24] |
Oram RA, Patel K, Hill A, et al. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults[J]. Diabetes Care, 2016, 39(3):337-344.
doi: 10.2337/dc15-1111
URL
|
| [25] |
Padilla-Martínez F, Collin F, Kwasniewski M, et al. Systematic review of polygenic risk scores for type 1 and type 2 diabetes[J]. Int J Mol Sci, 2020, 21(5):1703.
doi: 10.3390/ijms21051703
URL
|
